Company: MDCXW
Filing Date: 2025-04-25
Form Type: DRS
Source: 0001062993-25-007956
Chunk: 204

Company: Medicus Pharma Ltd.
Filing Date: 2025-04-25
Form: DRS
Chunk 204
---
7.5%) of the gross proceeds of such closing except for with respect to proceeds received from investors introduced by the Company, for which a cash placement fee equal to three percent (3.0%) of the gross proceeds attributable to such investors in the applicable closing shall be payable to the placement agent. In addition, we will also pay the placement agent up to $75,000 for fees and expenses of legal counsel and other out-of-pocket expenses out of the proceeds of the closing.

We or the placement agent may also ask other FINRA member broker-dealers that are registered with the SEC to participate as soliciting dealers for this offering. The placement agency agreement provides that the placement agent’s obligations are subject to conditions contained in the placement agency agreement.

We will deliver the securities being issued to the investors upon receipt of investor funds for the purchase of the securities offered pursuant to this prospectus. We expect to deliver the securities being offered pursuant to this prospectus on or about , 2025.

Indemnification

We have agreed to indemnify the placement agent against certain liabilities, including liabilities under the Securities Act and liabilities arising from breaches of representations and warranties contained in the placement agency agreement, or to contribute to payments that the placement agent may be required to make in respect of those liabilities.

<div align='center'>135</div>

| CONFIDENTIAL TREATMENT REQUESTED BY MEDICUS PHARMA LTD. 
 PURSUANT TO 17 C.F.R. SECTION 200.83                    |

Lock-Up Agreements

Each of our Directors and executive officers have agreed to a sixty (60) day “lock-up” period from the date of this prospectus with respect to the common shares that they beneficially own. This means that, for a period of sixty (60) days following the date of this prospectus, such persons may not offer, issuer, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any of our securities, subject to certain exceptions, without the prior written consent of the placement agent. We have also agreed, subject to certain exceptions (including with respect to the SEPA), to similar restrictions on the issuance, sale, disposal and registration of our securities for sixty (60) days following the date of this prospectus, without the prior written consent of the placement agent.

The placement agent has no present intention to waive or shorten the lock-up period; however, the terms of the lock-up agreements may be waived at its discretion. In determining whether to waive